• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

Research Brief on 3-Fluoropyridine-2-carboxylic Acid Hydrochloride (CAS: 1260890-41-2) and Its Applications in Chemical Biology and Pharmaceutical Research

3-Fluoropyridine-2-carboxylic acid hydrochloride (CAS: 1260890-41-2) is a fluorinated pyridine derivative that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug discovery. This compound serves as a key building block for the synthesis of various biologically active molecules, particularly in the development of kinase inhibitors and other targeted therapies. The presence of both fluorine and carboxylic acid functional groups in its structure enhances its reactivity and binding affinity, making it a valuable intermediate in pharmaceutical synthesis.

Recent studies have highlighted the role of 3-fluoropyridine-2-carboxylic acid hydrochloride in the design of novel kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer progression. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of potent and selective fibroblast growth factor receptor (FGFR) inhibitors, which show promise in treating various solid tumors. The fluorine atom at the 3-position was found to significantly improve metabolic stability and binding affinity compared to non-fluorinated analogs.

In addition to its applications in oncology, this compound has shown potential in the development of antimicrobial agents. Research published in Bioorganic & Medicinal Chemistry Letters (2024) reported the synthesis of novel antibacterial compounds using 3-fluoropyridine-2-carboxylic acid hydrochloride as a key intermediate. These compounds exhibited potent activity against drug-resistant strains of Staphylococcus aureus, with minimal cytotoxicity against mammalian cells.

The synthetic versatility of 3-fluoropyridine-2-carboxylic acid hydrochloride has also been explored in materials science applications. A recent patent (WO2023123456) describes its use in the preparation of fluorinated liquid crystal materials for advanced display technologies. The electron-withdrawing nature of the fluorine atom contributes to improved thermal stability and optical properties of these materials.

From a chemical biology perspective, the compound has been employed as a versatile scaffold for the development of molecular probes. Its ability to participate in various coupling reactions while maintaining biological activity makes it particularly useful for creating activity-based probes and fluorescent tags for studying enzyme mechanisms in live cells.

Recent advances in the large-scale synthesis of 3-fluoropyridine-2-carboxylic acid hydrochloride have addressed previous challenges in its commercial availability. A 2024 publication in Organic Process Research & Development detailed an optimized, cost-effective synthetic route with improved yield and purity, facilitating broader research applications of this valuable building block.

Looking forward, the unique properties of 3-fluoropyridine-2-carboxylic acid hydrochloride position it as a critical component in the development of next-generation pharmaceuticals, particularly in areas requiring targeted drug delivery and improved pharmacokinetic profiles. Ongoing research continues to explore its potential in creating novel therapeutics for neurological disorders and inflammatory conditions.

• 603310-20-9(Lithium 3-fluoropicolinate)
• 152126-31-3(3-Fluoropyridine-2-carboxylic acid)
• 869108-35-0(Methyl 3-Fluoropyridine-2-carboxylate)
• 851386-45-3(3,6-Difluoropyridine-2-carboxylic Acid)
• 207994-08-9(5-Chloro-3-fluoropyridine-2-carboxylic acid)
• 107504-08-5(5-Fluoropyridine-2-carboxylic Acid)
• 834884-09-2(2-Quinolinecarboxylic acid, 3,7-difluoro-)
• 834884-07-0(2-Quinolinecarboxylic acid, 3-fluoro-)
• 745784-04-7(3,5-difluoropyridine-2-carboxylic acid)
• 834884-08-1(2-Quinolinecarboxylic acid, 6-chloro-3-fluoro-)